DirectShifts Secures Investment from Experienced Healthcare Tech Investor, Serent Capital

DirectShifts Secures Investment from Experienced Healthcare Tech Investor, Serent Capital

The investment will fund continued expansion and enhanced product functionality

November 3, 2022

DirectShifts, a healthcare staffing platform that connects clinicians to hospitals and other providers, announced it received a strategic investment from Serent Capital, a growth-focused firm that invests in technology companies. The investment will support expansion into new markets and enhanced product functionality.

“DirectShifts set out to modernize healthcare recruiting and staffing, and we are profoundly grateful to our network of clinicians and providers for the strides we have made to date. To continue to serve the healthcare ecosystem’s growing needs for the workforce, we wanted a partner who shared our vision and excitement for the future,” Sai Thumuluru, Founder and CEO at DirectShifts, stated. “We built a strong relationship with the Serent Team, and it became clear that not only did they deeply understand the healthcare market, but they also had the resources to help us scale and deliver even more value to our network of clinicians and providers,” he concluded.

DirectShifts is a healthcare staffing platform that connects physicians, advanced practice providers, nurses, and allied health workers to hospitals and other healthcare providers for short-term shift work, contract work, and full-time roles. DirectShifts has automated much of the traditional agency, recruiter-led staffing model via its software platform, allowing customers to hire higher-quality staff faster, more efficiently, and cost-effectively compared to traditional agencies. The company helps providers focus on what is most important – delivering better care to patients.

Kevin Frick, Partner at Serent Capital, added, “Healthcare has been a core market for Serent since our founding, and we have a profound appreciation for the solution that Sai and the DirectShifts team have built.” He continued, “We look forward to partnering with the company to continue driving innovation within healthcare staffing and, more broadly, work to increase the efficiency of our healthcare system.”

Joining the DirectShifts board of directors will be Kevin Frick, Partner, and John Caselli, Principal, from Serent Capital. Mike Metzger, former CEO of Payscale and Raintree Systems along with Anita Pramoda, former CFO of Epic EMR Systems & board director of multiple healthcare companies will also be joining the company’s board.

DirectShifts’ platform is trusted by top hospitals and other healthcare employers across the country. The company’s platform has been recognized as a Top 10 Healthcare company by Smart Health.

Serent is an active investor in the healthcare market, having invested in over 20 healthcare technology companies in the last 10 years. Recent investments include EDH, Procurement Partners, and Raintree Systems. To learn more about Serent’s partnership with healthcare companies, visit: https://serentcapital.com/healthcare/.

Serent Capital invests in growing businesses that have developed compelling solutions that address their customers' needs. As those businesses grow and evolve, the opportunities and challenges that they face change with them. Principals at Serent Capital have firsthand experience at capturing those opportunities and navigating these difficulties through their experiences as CEOs, strategic advisors, and board members to successful growing businesses. By bringing its expertise and capital to bear, Serent seeks to help growing businesses thrive. Learn more about our portfolio companies.

Disclaimer:

This publication is for informational purposes only, and nothing contained herein constitutes an offer to sell or a solicitation of an offer to buy any interest in any investment vehicle managed by Serent Capital or any company in which Serent Capital or its affiliates have invested. An offer or solicitation will be made only through a final private placement memorandum, subscription agreement and other related documents with respect to a particular investment opportunity and will be subject to the terms and conditions contained in such documents, including the qualifications necessary to become an investor. Serent Capital does not utilize its website to provide investment or other advice, and nothing contained herein constitutes a comprehensive or complete statement of the matters discussed or the law relating thereto. Information provided reflects Serent Capital’s views as of a particular time and are subject to change without notice. You should obtain relevant and specific professional advice before making any investment decision.
Executive endorsements of Serent Capital are for illustrative purposes, designed to attract business development contacts, and should not be construed as a client or investor testimonial of Serent Capital's investment advisory services. All such endorsements are from current or former portfolio company leadership about Serent Capital’s ability to provide services to their companies. Certain executives are also investors in Serent Capital’s investment vehicle(s), and as such, there is an inherent conflict in that those executives have an incentive to provide favorable reviews of Serent Capital’s business practices for the benefit of the investment vehicles that they hold a personal ownership interest in. Serent Capital has not, directly or indirectly, paid any compensation to such individuals for their endorsements.
Certain information on this Website may contain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “aim”, “will” or similar expressions are intended to identify forward-looking statements. Serent Capital undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Past performance is not indicative of future results; no representation is being made that any investment or transaction will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided.